Trial Profile
Basis Plan For Postmarketing Survelillances, Etc Of New Ethical Drugs For Torisel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2020
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Pfizer Japan
- 04 Aug 2020 Results published in the Japanese Journal of Clinical Oncology
- 14 Sep 2018 Status changed from active, no longer recruiting to completed.
- 03 Apr 2017 Planned End Date changed from 1 Jun 2015 to 1 Jan 2018.